Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl van Walraven

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
JAMA Internal Medicine|September 15, 2015
The Utility of Unplanned Early Hospital Readmissions as a Health Care Quality IndicatorCarl van Walraven
Health Services Research|October 22, 2015
The Impact of Improved Population Life Expectancy in Survival Trend Analyses of Specific DiseasesCarl van Walraven
Journal of General Internal Medicine|June 15, 2019
The Influence of Inpatient Physician Continuity on Hospital DischargeCarl van Walraven
Journal of Clinical Epidemiology|February 8, 2017
Bootstrap imputation with a disease probability model minimized bias from misclassification due to administrative database codesCarl van Walraven
Medical Care|August 9, 2017
Improved Correction of Misclassification Bias With Bootstrap ImputationCarl van Walraven
Journal of Clinical Epidemiology|July 15, 2009
Individual patient meta-analysis--rewards and challengesCarl van Walraven
Journal of Clinical Epidemiology|June 30, 2014
The Hospital-patient One-year Mortality Risk score accurately predicted long-term death risk in hospitalized patientsCarl van Walraven
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?Carl van Walraven
Clinical Chemistry|December 26, 2001
Practice guidelines and practicing physicians-who's guiding whom?Carl van Walraven
ACP Journal Club|May 5, 2004
Ximelagatran was noninferior to warfarin in preventing stroke and systemic embolism in atrial fibrillationCarl Van Walraven
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
JAMA Internal Medicine|September 15, 2015
The Utility of Unplanned Early Hospital Readmissions as a Health Care Quality IndicatorCarl van Walraven
Health Services Research|October 22, 2015
The Impact of Improved Population Life Expectancy in Survival Trend Analyses of Specific DiseasesCarl van Walraven
Journal of General Internal Medicine|June 15, 2019
The Influence of Inpatient Physician Continuity on Hospital DischargeCarl van Walraven
Journal of Clinical Epidemiology|February 8, 2017
Bootstrap imputation with a disease probability model minimized bias from misclassification due to administrative database codesCarl van Walraven
Medical Care|August 9, 2017
Improved Correction of Misclassification Bias With Bootstrap ImputationCarl van Walraven
Journal of Clinical Epidemiology|July 15, 2009
Individual patient meta-analysis--rewards and challengesCarl van Walraven
Journal of Clinical Epidemiology|June 30, 2014
The Hospital-patient One-year Mortality Risk score accurately predicted long-term death risk in hospitalized patientsCarl van Walraven
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 12, 2020
Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?Carl van Walraven
Clinical Chemistry|December 26, 2001
Practice guidelines and practicing physicians-who's guiding whom?Carl van Walraven
ACP Journal Club|May 5, 2004
Ximelagatran was noninferior to warfarin in preventing stroke and systemic embolism in atrial fibrillationCarl Van Walraven
Pageof 27